Related Articles
Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models
Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells
Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer
Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells